TLR priming licenses NAIP inflammasome activation by immunoevasive ligands
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2412700121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von James P Grayczyk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Inflammasomes, Neuronal Apoptosis-Inhibitory Protein, Calcium-Binding Proteins, Toll-Like Receptors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH (NIH), NICHD NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
NLR family, apoptosis inhibitory proteins (NAIPs) detect bacterial flagellin and structurally related components of bacterial type III secretion systems (T3SS), and recruit NLR family CARD domain containing protein 4 (NLRC4) and caspase-1 into an inflammasome complex that induces pyroptosis. NAIP/NLRC4 inflammasome assembly is initiated by the binding of a single NAIP to its cognate ligand, but a subset of bacterial flagellins or T3SS structural proteins are thought to evade NAIP/NLRC4 inflammasome sensing by not binding to their cognate NAIPs. Unlike other inflammasome components such as NLRP3, AIM2, or some NAIPs, NLRC4 is constitutively present in resting macrophages and not known to be induced by inflammatory signals. Here, we demonstrate that Toll-like receptor (TLR)-dependent p38 mitogen-activated protein kinase signaling up-regulates NLRC4 transcription and protein expression in murine macrophages, which licenses NAIP detection of evasive ligands. In contrast, TLR priming in human macrophages did not up-regulate NLRC4 expression, and human macrophages remained unable to detect NAIP-evasive ligands even following priming. Critically, ectopic expression of either murine or human NLRC4 was sufficient to induce pyroptosis in response to immunoevasive NAIP ligands, indicating that increased levels of NLRC4 enable the NAIP/NLRC4 inflammasome to detect these normally evasive ligands. Altogether, our data reveal that TLR priming tunes the threshold for the murine NAIP/NLRC4 inflammasome to enable inflammasome responses against immunoevasive or suboptimal NAIP ligands. These findings provide insight into species-specific TLR regulation of NAIP/NLRC4 inflammasome activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104.
- Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.
- Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA 19104.
- Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.
- Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.
- Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.
ORCID-Profile: James P Grayczyk, Marisa S Egan, Sunny Shin, Igor E Brodsky
Förderung
- HHS | NIH (NIH)
- NICHD NIH HHS
- NIAID NIH HHS
- NSF | NSF Graduate Research Fellowship Program (GRFP)
Zitieren
APA
Grayczyk, J. P., Liu, L., Egan, M. S., Aunins, E., Wynosky-Dolfi, M. A., Canna, S. W., Minn, A. J., Shin, S., & Brodsky, I. E. (2024). TLR priming licenses NAIP inflammasome activation by immunoevasive ligands. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2412700121
Vancouver
Grayczyk JP, Liu L, Egan MS, Aunins E, Wynosky-Dolfi MA, Canna SW, et al. TLR priming licenses NAIP inflammasome activation by immunoevasive ligands. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2412700121
BibTeX
@article{Grayczyk2024,
author = {Grayczyk, James P and Liu, Luying and Egan, Marisa S and Aunins, Emily and Wynosky-Dolfi, Meghan A and Canna, Scott W and Minn, Andy J and Shin, Sunny and Brodsky, Igor E},
title = {TLR priming licenses NAIP inflammasome activation by immunoevasive ligands},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2412700121}
}
EUVIMED